SPRINT and BP targets of anthypertensive treatment
The results of the Systolic Blood Pressure Intervention Trial (SPRINT) have been recently published (New England Journal of Medicine, November 9, 2015).
This was a large trial including 9361 participants with Systolic Blood Pressure (SBP) ≥130 mmHg and high cardiovascular risk but no diabetes or previous stroke. They were treated to a SBP target <120 mmHg (intensive treatment) or to a target <140 mmHg (standard treatment).
May 17 World Hypertension Day 2017
Nowadays it is estimated that worldwide one billion people are hypertensives and 50% are unaware of the high cardiovascular risk. In Europe only 1 out of 2 who are treated for hypertension has their blood pressure controlled. This calls for action and the World Hypertension Day 2017 is the day for new initiatives to inform the public and to reshape our hypertension management.
In 2015 the ESH Excellence Centres celebrated 10 year of excellence in hypertension and cardiovascular prevention. The rationale for the ESH Excellence Centres was created and further elaborated at the ESH Educational Committee meeting in Italy in July 2005. The European Society of Hypertension (ESH) is making continuous efforts to manage the burden of hypertension in Europe by stimulating scientific exchange related to knowledge about hypertension, and supporting and building organizations committed to work for the control of hypertension.
Join a network of over 1600 hypertension professionals dedicated to scientific research and knowledge and to improving hypertension prevention, treatment and control.
– Eligibility to apply for ESH Hypertension Specialist status
– Eligibility to serve in a leadership capacity in an ESH Excellence Center
– Reduced Member registration fee for the ESH Annual Meeting
– Subscription to the Journal of Hypertension